Fig. 5.

Five-year grouped trend data for incidence, mortality and accrual by minority* status 2000–2019. Five-Year Trends from 2000 to 2019 shows increased accrual for minority patients from 3.2% (2000–2004) to 8.2% (2015–2019) over the 20 year period. *Data Source: Incidence—CBTRUS: Data provided by CDC’s National Program of Cancer Registries and NCI’s Surveillance, Epidemiology and End Results Program, 2000–2017, Mortality—Incidence-Based Mortality SEER Research Data, (2000–2017), Accrual—Systematic review of the literature published of clinical (Phase I–IV) trials of adult gliomas (2000–2019).